Biomarker discovery sheds new light on heart attack risk of arthritis drugs
Wednesday, December 10, 2014 - 16:31
in Health & Medicine
A class of drug for treating arthritis - all but shelved over fears about side effects - may be given a new lease of life, following the discovery of a possible way to identify which patients should avoid using it. A new study sheds light on the 10-year-old question of how COX-2 inhibitors -- a type of non-steroidal anti-inflammatory drug (NSAID) -- can increase the risk of heart attack in some people.